AttributesValues
rdf:type
Description
  • Backgrounds: The current renaissance of the interest in prognostic factors (PF) in multiple myeloma (MM) is determined by the extended possibilities of intensive treatment regimes, which require individual stratification of patients with a need of independent highly predictive prognostic factors. Design and Subjects: The prognostic significance of 7 selected staging systems and some cytokines and adhesive molecules was evaluated in the group of 237 patients with MM treated between 1991-2002 by conventional therapy.
  • Backgrounds: The current renaissance of the interest in prognostic factors (PF) in multiple myeloma (MM) is determined by the extended possibilities of intensive treatment regimes, which require individual stratification of patients with a need of independent highly predictive prognostic factors. Design and Subjects: The prognostic significance of 7 selected staging systems and some cytokines and adhesive molecules was evaluated in the group of 237 patients with MM treated between 1991-2002 by conventional therapy. (en)
Title
  • Prognostic factors and clinical staging systems in multiple myeloma in the group of 237 patients from the years 1991-2002 treated with conventional chemotherapy I. Prognostic significance of selected clinical and laboratory markers
  • Prognostic factors and clinical staging systems in multiple myeloma in the group of 237 patients from the years 1991-2002 treated with conventional chemotherapy I. Prognostic significance of selected clinical and laboratory markers (en)
skos:prefLabel
  • Prognostic factors and clinical staging systems in multiple myeloma in the group of 237 patients from the years 1991-2002 treated with conventional chemotherapy I. Prognostic significance of selected clinical and laboratory markers
  • Prognostic factors and clinical staging systems in multiple myeloma in the group of 237 patients from the years 1991-2002 treated with conventional chemotherapy I. Prognostic significance of selected clinical and laboratory markers (en)
skos:notation
  • RIV/61988987:17110/02:A1000VRZ!RIV10-MSM-17110___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • S
http://linked.open...iv/cisloPeriodika
  • 15
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 660625
http://linked.open...ai/riv/idVysledku
  • RIV/61988987:17110/02:A1000VRZ
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • Cytokines-cytoadhesive molecules; Multiple myeloma; Prognostic factors; Propidium-iodide proliferative index of plasmocytes; Thymidinkinase (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • CZ - Česká republika
http://linked.open...ontrolniKodProRIV
  • [10C6676559FD]
http://linked.open...i/riv/nazevZdroje
  • Klinická onkologie
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • suppl.
http://linked.open...iv/tvurceVysledku
  • Gumulec, Jaromír
  • Martínek, Arnošt
issn
  • 0862-495X
number of pages
http://localhost/t...ganizacniJednotka
  • 17110
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 77 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software